查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1748855

感染性傷口護理管理市場－全球產業規模、佔有率、趨勢、機會和預測（按產品類型、傷口類型、地區和競爭細分，2020-2030 年）

Infectious Wound Care Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Wound Type, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球感染性傷口護理管理市場規模達14.2億美元，預計2030年將以7.13%的複合年成長率成長。該市場涵蓋廣泛的產品和服務，旨在預防、治療和管理感染性傷口，這些傷口可能由損傷、手術或慢性疾病引起。這些傷口通常含有細菌或真菌等有害微生物，需要專門的護理來預防併發症。產品範圍包括抗菌敷料、外用抗生素、傷口清潔劑和高級護理解決方案。技術進步透過提高抗菌性能和促進組織再生，不斷增強傷口護理產品的功效。糖尿病和肥胖症等慢性疾病的日益普及也增加了對有效傷口護理解決方案的需求。隨著全球醫療保健系統對早期介入和感染控制的重視，感染性傷口護理管理產業將迎來穩定持續的成長。

市場概覽
預測期 2026-2030
2024年市場規模 14.2億美元
2030年市場規模 21.3億美元
2025-2030 年複合年成長率 7.13%
成長最快的領域 糖尿病
最大的市場 北美洲

關鍵市場促進因素

慢性病發生率上升

主要市場挑戰

抗菌素抗藥性

主要市場趨勢

再生醫學

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球感染性傷口照護管理市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品類型（治療學、設備）
    • 依傷口類型（糖尿病、缺氧/組織灌注不良、其他）
    • 按地區（北美、歐洲、亞太、南美、中東和非洲）
    • 按公司分類（2024）
  • 產品市場圖
    • 依產品類型
    • 按傷口類型
    • 按地區

第6章：北美感染性傷口照護管理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲感染性傷口照護管理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區感染性傷口照護管理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲

第9章：南美洲感染性傷口照護管理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲感染性傷口照護管理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購
  • 產品開發
  • 最新動態

第 13 章：波特的分析

第 14 章：PESTEL 分析

第 15 章：競爭格局

  • Molnlycke Health Care AB
  • Hartmann Group
  • Smith & Nephew PLC
  • 3M Company.
  • Smith & Nephew PLC
  • Medtronic Plc
  • B Braun Melsungen AG
  • Johnson & Johnson
  • Molnlycke Healthcare AB
  • Conva Tec Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 16186

The Global Infectious Wound Care Management Market was valued at USD 1.42 billion in 2024 and is projected to grow at a CAGR of 7.13% through 2030. This market encompasses a broad spectrum of products and services aimed at preventing, treating, and managing infectious wounds, which may arise from injuries, surgeries, or chronic health conditions. These wounds are characterized by the presence of harmful microorganisms such as bacteria or fungi and require specialized care to prevent complications. The product range includes antimicrobial dressings, topical antibiotics, wound cleansers, and advanced care solutions. Technological advancements continue to enhance the efficacy of wound care products by improving antimicrobial performance and tissue regeneration. The increasing prevalence of chronic conditions like diabetes and obesity has also heightened the demand for effective wound care solutions. As healthcare systems globally emphasize early intervention and infection control, the infectious wound care management sector is set to witness steady and sustained growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.42 Billion
Market Size 2030USD 2.13 Billion
CAGR 2025-20307.13%
Fastest Growing SegmentDiabetes Mellitus
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Chronic Diseases

The surge in chronic diseases is a major catalyst for the global Infectious Wound Care Management Market. According to the World Obesity Atlas 2024, the number of adults living with obesity is projected to rise from 0.81 billion in 2020 to 1.53 billion by 2035. Chronic conditions such as diabetes, vascular disorders, and autoimmune diseases frequently lead to non-healing wounds, pressure sores, and ulcers, all of which are highly susceptible to infection. These patients often require specialized wound care solutions due to compromised immunity and delayed healing. As the global population continues to age and the burden of non-communicable diseases escalates, healthcare providers are increasingly turning to advanced wound care technologies. The focus on infection prevention, patient recovery, and quality of life has intensified demand for effective infectious wound care management products, driving market expansion and encouraging innovation across product categories.

Key Market Challenges

Antimicrobial Resistance

Antimicrobial resistance (AMR) presents a substantial challenge to the Global Infectious Wound Care Management Market. AMR occurs when pathogens become resistant to antimicrobial agents, reducing the efficacy of traditional treatments such as antibiotics and antifungal medications. This phenomenon complicates the management of infected wounds, often leading to prolonged healing times, higher healthcare expenditures, and increased risk of severe complications. In the context of wound care, AMR diminishes the effectiveness of commonly used therapies, necessitating the development of alternative strategies. These may include novel antimicrobial compounds, combination therapies, or non-antibiotic interventions. Ensuring appropriate antibiotic use and implementing rigorous infection control protocols are critical in mitigating AMR. As the global health community continues to address this issue, innovation in resistant-pathogen management and infection prevention becomes increasingly vital to maintaining the effectiveness of wound care solutions.

Key Market Trends

Regenerative Medicine

Regenerative medicine is emerging as a transformative trend in the Infectious Wound Care Management Market. This field leverages the body's natural healing mechanisms through the application of technologies such as stem cell therapy, growth factors, and tissue engineering to accelerate wound healing and tissue repair. These approaches are particularly effective for treating chronic or complex infectious wounds that are unresponsive to conventional treatments. Stem cells promote regeneration by differentiating into the necessary cell types, while growth factors aid in tissue proliferation and remodeling. Regenerative solutions not only reduce healing time but also help prevent infections and improve long-term outcomes. Although still under active research, regenerative medicine is poised to revolutionize wound care, offering innovative alternatives that enhance patient recovery, reduce healthcare costs, and address complications arising from non-healing wounds.

Key Market Players

  • Molnlycke Health Care AB
  • Hartmann Group
  • Smith & Nephew PLC
  • 3M Company
  • Medtronic Plc
  • B Braun Melsungen AG
  • Johnson & Johnson
  • Molnlycke Healthcare AB
  • Conva Tec Inc.

Report Scope:

In this report, the Global Infectious Wound Care Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infectious Wound Care Management Market, By Product Type:

  • Therapeutics
  • Device

Infectious Wound Care Management Market, By Wound Type:

  • Diabetes Mellitus
  • Hypoxia/Poor Tissue Perfusion
  • Other

Infectious Wound Care Management Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Infectious Wound Care Management Market.

Available Customizations:

Global Infectious Wound Care Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Types
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Infectious Wound Care Management Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Therapeutics, Device)
    • 5.2.2. By Wound Type (Diabetes Mellitus, Hypoxia/Poor Tissue Perfusion, Other)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Product Type
    • 5.3.2. By Wound Type
    • 5.3.3. By Region

6. North America Infectious Wound Care Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Wound Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Infectious Wound Care Management Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Wound Type
    • 6.3.2. Canada Infectious Wound Care Management Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Wound Type
    • 6.3.3. Mexico Infectious Wound Care Management Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Wound Type

7. Europe Infectious Wound Care Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Wound Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Infectious Wound Care Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Wound Type
    • 7.3.2. France Infectious Wound Care Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Wound Type
    • 7.3.3. United Kingdom Infectious Wound Care Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Wound Type
    • 7.3.4. Italy Infectious Wound Care Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Wound Type
    • 7.3.5. Spain Infectious Wound Care Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Wound Type

8. Asia-Pacific Infectious Wound Care Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Wound Type
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Infectious Wound Care Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Wound Type
    • 8.3.2. Japan Infectious Wound Care Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Wound Type
    • 8.3.3. India Infectious Wound Care Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Wound Type
    • 8.3.4. South Korea Infectious Wound Care Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Wound Type
    • 8.3.5. Australia Infectious Wound Care Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Wound Type

9. South America Infectious Wound Care Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Wound Type
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Infectious Wound Care Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Wound Type
    • 9.3.2. Argentina Infectious Wound Care Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Wound Type
    • 9.3.3. Colombia Infectious Wound Care Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Wound Type

10. Middle East and Africa Infectious Wound Care Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Wound Type
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Infectious Wound Care Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Wound Type
    • 10.3.2. Saudi Arabia Infectious Wound Care Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Wound Type
    • 10.3.3. South Africa Infectious Wound Care Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Wound Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition
  • 12.2. Product Development
  • 12.3. Recent Developments

13. Porter's analysis

14. PESTEL analysis

15. Competitive Landscape

  • 15.1. Molnlycke Health Care AB
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
  • 15.2. Hartmann Group
  • 15.3. Smith & Nephew PLC
  • 15.4. 3M Company.
  • 15.5. Smith & Nephew PLC
  • 15.6. Medtronic Plc
  • 15.7. B Braun Melsungen AG
  • 15.8. Johnson & Johnson
  • 15.9. Molnlycke Healthcare AB
  • 15.10. Conva Tec Inc.

16. Strategic Recommendations

17. About Us & Disclaimer